Chrishan J Nalliah1, Prashanthan Sanders2, Jonathan M Kalman3. 1. The Department of Cardiology, Royal Melbourne Hospital and the Department of Medicine, University of Melbourne, Melbourne, 3050, Australia. 2. Centre for Heart Rhythm Disorders (CHRD), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia. 3. The Department of Cardiology, Royal Melbourne Hospital and the Department of Medicine, University of Melbourne, Melbourne, 3050, Australia. jon.kalman@mh.org.au.
Abstract
PURPOSE OF REVIEW: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans, affecting more than 33 million people globally. Its association with complex, resource intensive medical conditions such as stroke, heart failure and dementia have had profound impacts across existing health care structures. The global prevalence of AF has enjoyed significant growth despite significant improvement in our armamentarium for arrhythmia treatment. RECENT FINDINGS: Efforts aimed at curtailing the incidence, prevalence, or progression of AF have prompted re-evaluation of traditional frameworks for understanding and managing this debilitating disease. It is in this context that focus has shifted toward lifestyle-associated factors such as obesity, hypertension, sleep apnoea, exercise, alcohol and diet, as mechanistic drivers and putative targets for therapy. Compelling evidence exists for weight loss and management of associated risk factors to improve outcomes of AF treatment. This review will address the epidemiologic and mechanistic evidence that link lifestyle-associated factors with AF and in light of this analysis evaluate the clinical impacts of their upstream management. Traditional paradigms of AF are shifting in light of emerging evidence, such that risk factor modification has become positioned as the fourth pillar of AF management.
PURPOSE OF REVIEW: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in humans, affecting more than 33 million people globally. Its association with complex, resource intensive medical conditions such as stroke, heart failure and dementia have had profound impacts across existing health care structures. The global prevalence of AF has enjoyed significant growth despite significant improvement in our armamentarium for arrhythmia treatment. RECENT FINDINGS: Efforts aimed at curtailing the incidence, prevalence, or progression of AF have prompted re-evaluation of traditional frameworks for understanding and managing this debilitating disease. It is in this context that focus has shifted toward lifestyle-associated factors such as obesity, hypertension, sleep apnoea, exercise, alcohol and diet, as mechanistic drivers and putative targets for therapy. Compelling evidence exists for weight loss and management of associated risk factors to improve outcomes of AF treatment. This review will address the epidemiologic and mechanistic evidence that link lifestyle-associated factors with AF and in light of this analysis evaluate the clinical impacts of their upstream management. Traditional paradigms of AF are shifting in light of emerging evidence, such that risk factor modification has become positioned as the fourth pillar of AF management.
Authors: Alexander R van Rosendael; Aukelien C Dimitriu-Leen; Philippe J van Rosendael; Melissa Leung; Jeff M Smit; Antti Saraste; Juhani Knuuti; Rob J van der Geest; Britt W H van der Arend; Erik W van Zwet; Arthur J Scholte; Victoria Delgado; Jeroen J Bax Journal: Circ Arrhythm Electrophysiol Date: 2017-02
Authors: Melissa E Middeldorp; Rajeev K Pathak; Megan Meredith; Abhinav B Mehta; Adrian D Elliott; Rajiv Mahajan; Darragh Twomey; Celine Gallagher; Jeroen M L Hendriks; Dominik Linz; R Doug McEvoy; Walter P Abhayaratna; Jonathan M Kalman; Dennis H Lau; Prashanthan Sanders Journal: Europace Date: 2018-12-01 Impact factor: 5.214
Authors: Ratika Parkash; George A Wells; John L Sapp; Jeffrey S Healey; Jean-Claude Tardif; Isabelle Greiss; Lena Rivard; Jean-Francois Roux; Lorne Gula; Isabelle Nault; Paul Novak; David Birnie; Andrew Ha; Stephen B Wilton; Iqwal Mangat; Christopher Gray; Martin Gardner; Anthony S L Tang Journal: Circulation Date: 2017-02-22 Impact factor: 29.690
Authors: Teresa S M Tsang; Marion E Barnes; Yoko Miyasaka; Stephen S Cha; Kent R Bailey; Grace C Verzosa; James B Seward; Bernard J Gersh Journal: Eur Heart J Date: 2008-07-08 Impact factor: 29.983
Authors: Dennis H Lau; Melissa E Middeldorp; Anthony G Brooks; Anand N Ganesan; Kurt C Roberts-Thomson; Martin K Stiles; Darryl P Leong; Hany S Abed; Han S Lim; Christopher X Wong; Scott R Willoughby; Glenn D Young; Jonathan M Kalman; Walter P Abhayaratna; Prashanthan Sanders Journal: PLoS One Date: 2013-10-03 Impact factor: 3.240
Authors: Revati S Dewal; Amara Greer-Short; Cemantha Lane; Shinsuke Nirengi; Pedro Acosta Manzano; Diego Hernández-Saavedra; Katherine R Wright; Drew Nassal; Lisa A Baer; Peter J Mohler; Thomas J Hund; Kristin I Stanford Journal: Int J Obes (Lond) Date: 2021-01-26 Impact factor: 5.095
Authors: G Craig Wood; Lisa Bailey-Davis; Peter Benotti; Adam Cook; James Dove; Jacob Mowery; Abhilasha Ramasamy; Neeraj Iyer; B Gabriel Smolarz; Neela Kumar; Christopher D Still Journal: PLoS One Date: 2021-11-03 Impact factor: 3.240
Authors: Emelia J Benjamin; Sana M Al-Khatib; Patrice Desvigne-Nickens; Alvaro Alonso; Luc Djoussé; Daniel E Forman; Anne M Gillis; Jeroen M L Hendriks; Mellanie True Hills; Paulus Kirchhof; Mark S Link; Gregory M Marcus; Reena Mehra; Katherine T Murray; Ratika Parkash; Ileana L Piña; Susan Redline; Michiel Rienstra; Prashanthan Sanders; Virend K Somers; David R Van Wagoner; Paul J Wang; Lawton S Cooper; Alan S Go Journal: J Am Heart Assoc Date: 2021-08-05 Impact factor: 6.106